LONDON--(BUSINESS WIRE)--The global orthostatic hypotension (OH) drugs market is expected to post a CAGR close to 8% during the period 2019-2023, according to the latest market research report by Technavio.
OH is associated with various chronic neurodegenerative diseases, cardiovascular diseases, and diabetes. The prevalence of neurodegenerative diseases is increasing worldwide, which raises the risk of OH. Cardiovascular diseases can cause OH due to the heart's inability to pump enough blood. Dehydration, which is a common condition in people with uncontrolled diabetes as a result of frequent urination, increases the risk of OH. Diabetes can also cause damage to nerves supplying blood vessels, which can lead to a drop in blood pressure on standing up. Hence, the rising prevalence of chronic neurodegenerative diseases, cardiovascular diseases, and diabetes, which increase the risk of OH, will drive the global OH drugs market.
As per Technavio, the use of combination therapy in OH treatment will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global orthostatic hypotension drugs market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
Global Orthostatic Hypotension Drugs Market: Use of Combination Therapy in OH Treatment
OH is a chronic, debilitating illness that is difficult to treat in several patients. Several drugs are used to improve postural symptoms, standing time, and function. Single drug therapy may not be adequate in treating OH patients as orthostatic stress varies with circumstances during the day. Hence, there is an increasing focus on the use of a combination of various drugs such as midodrine and fludrocortisone, midodrine and pyridostigmine, or midodrine and octreotide for the management of symptomatic OH. For example, in patients with OH refractory to treatment, combination therapy is considered. Fludrocortisone and midodrine in low doses can be used in combination if these agents fail to improve symptoms as a standalone therapy. Thus, with such advances in therapy, the market for OH drugs is expected to showcase a positive outlook during the forecast period.
“Apart from the use of combination therapy in OH treatment, R&D of new drugs for OH treatment, high market growth opportunities for OH drugs in emerging countries, and the adoption of fludrocortisone as an off-label first-line pharmacotherapy are some other major factors that will market growth during the forecast period,” says a senior analyst at Technavio.
Global Orthostatic Hypotension Drugs Market: Segmentation Analysis
This market research report segments the global orthostatic hypotension drugs market by product (midodrine, Northera (droxidopa), fludrocortisone, and other drugs) and geographical regions (North America, Europe, Asia, and ROW).
The North American region led the market in 2018, followed by Europe, Asia, and ROW, respectively. However, during the forecast period, the Asian region is expected to register the highest incremental growth due to the rapidly growing geriatric population and increasing prevalence of chronic diseases associated with a high risk of OH.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
